Physician profile
Katherine Dodd
NPI 1568738557
$3,616.43
in general payments reported to CMS, 2019-2025
15 companies · $86.29 in 2025
The $86.29 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $962 · 2020: $612 · 2021: $68.70 · 2022: $1,462 · 2023: $41.94 · 2024: $384 · 2025: $86.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,295.19 | 2022 | |
| Medtronic Vascular, INC. | $961.98 | 2019 | |
| Abiomed | $513.22 | 2020-2024 | Impella |
| Abbott Laboratories | $238.52 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $226.49 | 2022-2024 | Rhythmia Mapping System |
| Astrazeneca Pharmaceuticals LP | $99.75 | 2022-2023 | Farxiga |
| Impulse Dynamics (USA) INC. | $73.68 | 2024 | Optimizer |
| Kestra Medical Technology Services, INC. | $44.65 | 2024 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.63 | 2020-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $28.23 | 2021-2024 | |
| Daiichi Sankyo INC. | $24.09 | 2025 | Injectafer |
| E.R. Squibb & Sons, L.L.C. | $20.37 | 2025 | Camzyos |
| Merck Sharp & Dohme LLC | $18.30 | 2021 | |
| Alnylam Pharmaceuticals INC. | $18.21 | 2021 | |
| Pfizer INC. | $16.12 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Dodd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.